Skip to Main Content

The biopharma industry is reeling in the wake of president-elect Donald Trump’s heavy-handed words at his first press conference on Wednesday, where he said he’d get drug pricing under control.

“They’re getting away with murder,” Trump said. “Pharma has a lot of lobbies, a lot of lobbyists, and a lot of power.”


How is this resonating with the biopharma investment community?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!